These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5516219)

  • 41. [Experimental immunization with live anthrax STI vaccine using a needleless injector].
    Saltykov RA; Nekrasov IL; Lesniak OT; Ulanova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 May; 48(5):52-5. PubMed ID: 5560807
    [No Abstract]   [Full Text] [Related]  

  • 42. Anthrax. Biological and immunological principles of diagnosis and prevention. 3. Biological, biochemical and immunological study of anthraxin.
    Shlyakhov EN; Shvarts SA
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):139-42. PubMed ID: 5463706
    [No Abstract]   [Full Text] [Related]  

  • 43. [The experimental evaluation with flow cytofluorimetry technique of the level of cellular immunologic memory in persons vaccinated against plague and anthrax].
    Bogacheva NV; Kriuchkov AV; Darmov IV; Vorob'ev KA; Pechenkin DV; Elagin GD; Kolesnikiov DP
    Klin Lab Diagn; 2013 Nov; (11):48-53. PubMed ID: 24640112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practicalities of warfare required service personnel to be vaccinated against anthrax.
    Blain P; Lightfoot N; Bannister B
    BMJ; 1998 Oct; 317(7165):1077-8. PubMed ID: 9774304
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the criteria for usefulness and methods for the control of anthrax vaccine STI].
    IVASHKEVICH PA; MIKHAILOV BIa; ROZHKOV GI; TAMARIN AL
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Nov; 30():45-7. PubMed ID: 14406135
    [No Abstract]   [Full Text] [Related]  

  • 46. [Sporadic cases of the cutaneous form of anthrax].
    Baklanova AV; Shugaĭlo VT; Dorofeeva RP; Starik AD; Tishchenko AN
    Vrach Delo; 1987 Nov; (11):113-4. PubMed ID: 3439108
    [No Abstract]   [Full Text] [Related]  

  • 47. [The white mouse as an immunologic model in anthrax].
    Saltykov RA; Lesniak OT; Ulanova AA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Aug; 48(8):87-91. PubMed ID: 5099101
    [No Abstract]   [Full Text] [Related]  

  • 48. [Role of the nervous system im immunogenesis in vaccination with dead bacterial cultures].
    TERENT'EV FA; STEFANOVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Feb; 2():20-4. PubMed ID: 13147507
    [No Abstract]   [Full Text] [Related]  

  • 49. Anthrax vaccination.
    Meldrum KC
    Vet Rec; 1989 Aug; 125(6):136. PubMed ID: 2773257
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experience in massive aerogenic vaccination against anthrax].
    ALEKSANDROV NI; GEFEN NE; GARIN NS; GAPOCHKO KG; SERGEV VM; SMIRNOV MS; TAMARIN AL; SHLIAKHOV EN
    Voen Med Zh; 1959 Aug; 8():27-32. PubMed ID: 13792503
    [No Abstract]   [Full Text] [Related]  

  • 51. [Dynamics of immuno-allergic and morphological reactions in experimental anthrax vaccination].
    Shliakhov EN; Shroĭt IG; Burdenko TA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Mar; 42(3):106-11. PubMed ID: 5882762
    [No Abstract]   [Full Text] [Related]  

  • 52. Cutaneous anthrax--the non-industrial hazard.
    Lamb R
    Br Med J; 1969 Mar; 1(5644):641. PubMed ID: 5766138
    [No Abstract]   [Full Text] [Related]  

  • 53. [Trial study of the anthraxin test in the diagnosis and immunology of anthrax].
    Obnosova NV; Shuliak VP; Zykov MF; Vermul MS
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):119-21. PubMed ID: 5615847
    [No Abstract]   [Full Text] [Related]  

  • 54. Cutaneous manifestations of systemic diseases in children.
    Margileth AM
    Mod Probl Paediatr; 1975; 17():177-9. PubMed ID: 1186673
    [No Abstract]   [Full Text] [Related]  

  • 55. [Some peculiarities of the clinical manifestations and course of the cutaneous form of malignant anthrax in the Samarkandsk region].
    GRISHKO NP
    Med Zh Uzb; 1962 Nov; 11():46-9. PubMed ID: 13950578
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative clinical characteristics of the cutaneous form of anthrax among adults and children vaccinated and unvaccinated with STI vaccine].
    Baĭgel'dieva AB
    Sov Zdravookhr Kirg; 1970; 6():40-3. PubMed ID: 5516219
    [No Abstract]   [Full Text] [Related]  

  • 57. Anthrax vaccination in the Millennium Cohort: validation and measures of health.
    Smith B; Leard CA; Smith TC; Reed RJ; Ryan MA;
    Am J Prev Med; 2007 Apr; 32(4):347-53. PubMed ID: 17383567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anthrax. Biological and immunological principles of diagnosis and prevention. 4. The dynamics and intensity of skin tests with anthraxin in guinea pigs inoculated with a STI vaccine.
    Shlyakhov EN
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):464-8. PubMed ID: 4992904
    [No Abstract]   [Full Text] [Related]  

  • 59. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):341-5. PubMed ID: 10817479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of novel vaccines against anthrax in man.
    Stepanov AV; Marinin LI; Pomerantsev AP; Staritsin NA
    J Biotechnol; 1996 Jan; 44(1-3):155-60. PubMed ID: 8717399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.